Back to News
Market Impact: 0.2
Medpace Holdings Consensus Price Target Increased by 11.73% to $664.95
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year price target for Medpace Holdings was revised to $664.95 per share, up 11.73% from the prior $595.15 estimate dated October 20, 2026. The figures are described as an aggregate analyst consensus; the article excerpt gives no share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
MEDP0.35
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares